Linde PLC
LIN- Exchange
- Nasdaq
- Industry
- Industrial Inorganic Chemicals
- SEC CIK
- 0001707925
In the last 90 days, Linde PLC insiders filed 1 open-market purchase and 0 sales; 2,355 institutions reported holding it in 13F filings for Q2 2026, worth $205.4B in total; 6 superinvestors hold it, including Lone Pine Capital and D1 Capital Partners.
13F holders, Q2 2022
Institutional positions in Linde PLC as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 1,425
- −4 vs. Q1 2022
- Shares held
- 392.4M
- +11.1M (+2.9%) vs. Q1 2022
- Total value
- $112.7B
- −$8.19B (−6.8%) vs. Q1 2022
- New holders
- 119
- 589 more added
- Sold out
- 123
- 469 more reduced
21 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LIN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2,355 | $205.4B |
| Q1 2026 | 2,295 | $193.7B |
| Q4 2025 | 2,135 | $166.7B |
| Q3 2025 | 2,119 | $178.4B |
| Q2 2025 | 2,104 | $180.8B |
| Q1 2025 | 2,068 | $180.3B |
| Q4 2024 | 2,011 | $163.5B |
| Q3 2024 | 1,923 | $185.6B |
| Q2 2024 | 1,862 | $170.1B |
| Q1 2024 | 1,863 | $183.7B |
| Q4 2023 | 1,804 | $164.2B |
| Q3 2023 | 1,642 | $150.0B |
| Q2 2023 | 1,608 | $154.7B |
| Q1 2023 | 1,509 | $144.3B |
| Q4 2022 | 1,535 | $126.6B |
| Q3 2022 | 1,400 | $106.5B |
| Q2 2022 | 1,425 | $112.7B |
| Q1 2022 | 1,450 | $121.5B |
| Q4 2021 | 1,432 | $130.3B |
| Q3 2021 | 1,310 | $111.6B |
| Q2 2021 | 1,312 | $110.6B |
| Q1 2021 | 1,257 | $110.6B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Linde PLC; share changes are against Q1 2022.